References
- Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2013;64:118–40.
- Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004;46:547–54.
- McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011;185:1793–803.
- AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003;170:530–47.
- Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, Schain M, et al. Feedback microwave thermotherapy versus TURP for clinical BPH – a randomized controlled multicenter study. Urology 2002;60:292–9.
- Gravas S, Laguna MP, de la Rosette JJ. Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with 1-year follow-up. J Endourol 2003;17:425–30.
- Mattiasson A, Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, et al. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology 2007;69:91–6; discussion 6–7.
- Wagrell L, Sundin A, Norlen B. Intraprostatic blood-flow changes during ProstaLund feedback treatment measured by positron emission tomography. J Endourol 2005;19:873–7.
- Schelin S. Mediating transurethral microwave thermotherapy by intraprostatic and periprostatic injections of mepivacaine epinephrine: effects on treatment time, energy consumption, and patient comfort. J Endourol 2002;16:117–21.
- Schelin S, Claezon A, Sundin A, Wagrell L. Effects of intraprostatic and periprostatic injections of mepivacaine epinephrine on intraprostatic blood flow during transurethral microwave thermotherapy: correlation with [15O.H2O-PET. J Endourol 2004;18:965–70.
- Knutson T, Johansson A, Damber JE, Fall M, Vesely S, Peeker R. Intraurethral prostate injections with mepivacaine epinephrine: effects on patient comfort, treatment time and energy consumption during high-energy transurethral microwave thermotherapy. Scand J Urol Nephrol 2009;43:300–6.
- Clegg EJ. The arterial supply of the human prostate and seminal vesicles. J Anat 1955;89:209–16.
- Clegg EJ. The vascular arrangements within the human prostate gland. Br J Urol 1956;28:428–35.
- O'Leary MP. Validity of the “bother score” in the evaluation and treatment of symptomatic benign prostatic hyperplasia. Rev Urol 2005;7:1–10.
- de Wildt MJ, Tubaro A, Hofner K, Carter SS, de la Rosette JJ, Devonec M. Responders and nonresponders to transurethral microwave thermotherapy: a multicenter retrospective analysis. J Urol 1995;154:1775–8.
- Bolmsjö M, Schelin S, Wagrell L, Larson T, de la Rosette JJ, Mattiasson A. Cell-kill modeling of microwave thermotherapy for treatment of benign prostatic hyperplasia. J Endourol 2000;14:627–35.
- Huidobro C, Bolmsjo M, Larson T, de la Rosette J, Wagrell L, Schelin S, et al. Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping. J Urol 2004;171:672–8.
- Vesely S, Muller M, Knutson T, Peeker R, Hellstrom M, Dahlstrand C. Transurethral microwave thermotherapy of the prostate – evaluation with MRI and analysis of parameters relevant to outcome. Scand J Urol Nephrol 2008;42:53–8.